|
Real-time
Oslo Bors
13:51:19 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.5680 NOK | 0.00% |
|
-0.35% | -86.79% |
| 10-13 | Induct AS Expands Scope of Existing Severe Asthma Care Pathway | CI |
| 08-13 | Induct AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Induct
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 134.6 | 17.78 | - | - |
| Change | - | -86.79% | - | - |
| Enterprise Value (EV) 1 | 134.6 | 14.18 | 22.48 | 26.38 |
| Change | - | -89.46% | 58.52% | 17.35% |
| P/E | - | -2.27x | -3.79x | -18.9x |
| PBR | - | - | - | - |
| PEG | - | - | 0.1x | 0.2x |
| Capitalization / Revenue | 8.12x | 1.24x | 1.08x | 0.72x |
| EV / Revenue | 8.12x | 0.99x | 1.36x | 1.07x |
| EV / EBITDA | - | 3.94x | 3.41x | 2.06x |
| EV / EBIT | - | -1.59x | -3.75x | 264x |
| EV / FCF | - | -3.55x | -5.62x | -26.4x |
| FCF Yield | - | -28.2% | -17.8% | -3.79% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | -0.25 | -0.15 | -0.03 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 16.58 | 14.3 | 16.5 | 24.6 |
| EBITDA 1 | - | 3.6 | 6.6 | 12.8 |
| EBIT 1 | - | -8.9 | -6 | 0.1 |
| Net income 1 | -7.14 | -9.9 | -7.2 | -1.5 |
| Net Debt 1 | - | -3.6 | 4.7 | 8.6 |
| Reference price 2 | 4.3000 | 0.5680 | 0.5680 | 0.5680 |
| Nbr of stocks (in thousands) | 31,309 | 31,309 | - | - |
| Announcement Date | 2/12/26 A | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.99x | 3.94x | - | 1.91M | ||
| 26.96x | 9.94x | 16.21x | 0.72% | 3,946B | ||
| 128.17x | 56.68x | 92.27x | -.--% | 478B | ||
| 19.65x | 5.66x | 9.86x | 1.53% | 396B | ||
| 254.87x | 22.75x | 66.61x | -.--% | 329B | ||
| 29.49x | 6.03x | 18.74x | 1.26% | 274B | ||
| 2680.2x | 44.91x | 146.93x | -.--% | 275B | ||
| 98.26x | 9.75x | 26.09x | -.--% | 160B | ||
| 60.22x | 16.14x | 42.53x | -.--% | 136B | ||
| 13.62x | 3.62x | 7.57x | -.--% | 96.66B | ||
| Average | 367.94x | 17.65x | 43.07x | 0.39% | 608.93B | |
| Weighted average by Cap. | 169.07x | 15.46x | 31.21x | 0.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- INDCT Stock
- Valuation Induct
Select your edition
All financial news and data tailored to specific country editions
















